NSE-controlled carboxyl-terminus of APP gene over-expressing in transgenic mice induces altered expressions in behavior, Aβ-42, and GSK3β binding proteins

Cellular and Molecular Neurobiology

Volumn 25, Issue 5, 2005, Pages 833-850

  Lim, Hwa J ^a   Cho, Jung S ^a   Oh, Jae H ^a   Shim, Sun B ^a   Hwang, Dae Y ^a   Jee, Seung W ^a   Lee, Su H ^a   Sheen, Yhun Y ^b   Lee, Seok H ^a   Kim, Yong K ^a,c  

^a Korea Food and Drug Administration   (South Korea)

^b Ewha Womans University   (South Korea)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Alzheimer; APP; Catenin; GSK3; Transgenic

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BETA CATENIN; GAMMA SECRETASE; GLYCOGEN SYNTHASE KINASE 3BETA; NEURON SPECIFIC ENOLASE; TAU PROTEIN;

ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN LEVEL; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE LOCATION; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; MAZE TEST; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSGENE; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BASE SEQUENCE; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; FEMALE; GLYCOGEN SYNTHASE KINASE 3; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PHOSPHOPYRUVATE HYDRATASE; PROMOTER REGIONS (GENETICS); PROTEIN STRUCTURE, TERTIARY; TRANSGENES;

MUS MUSCULUS;

EID: 23844435090     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-005-4937-7     Document Type: Article

References (44)

1. Abe, K., and Saito, H. (2000). Amyloid β neurotoxicity not mediated by the mitogen-activated protein kinase cascade in cultured and hippocampal and cortical neurons. Neurosci. Lett. 292:1-4.
2. Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., and van Hoesen, G. W. (1991). The topographical and neuroanatomical distribution of neurofibrillary tangles and neurotic plaques in the cerebral cortex of patient with Alzheimer's disease. Cereb. Cortex 1:103-106.
3. Bard, F., Cannon, C., Barbour, R., Burke, R. L., Games, D., Grajeda, H., Guida, T., Hu, K., Hung, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Lieberburg, I., Motter, R., Nguten, M., Soriano, F., Vasquenz, N., Weiss, K., Welch, B., Seuber, P., Schenk, D., and Yednock, T. (2000). Peripherally administered antibodies agonist amyloid β-peptide enter the nervous system and reduce pathology in a mouse model of Alzheimer's disease. Nat. Med. 6:916-919.
4. Cassone, A., Conti, S., Bernards, F. D., and Polonelli, L. (1997). Antibodies, killer toxins and antifungal immunoprecipitation: A lesson fromnature? Immunol. Today 18:164-169.
5. Choi, S. H., Park, C. H., Koo, J. W., Seo, J. H., Kim, H. S., Jeong, S. J., Lee, J. H., Kim, S. S., and Suh, Y. H. (2001). Memory impairment and cholinergic dysfunction by centrally administered Abeta and carboxyl-terminal fragment of Alzheimer's APP in mice. FASEB J. 15:1816-1818.
6. Citron, M., Diehl, T., S., Gordon, G., Biere, A. L., Seubert, P., and Selkoe, D. J. (1996). Evidence that the 42- and 40-amino acid forms of amyloid β protein are generated from the β-amyloid precussor protein by different protease activities. Proc. Natl. Acad. Sci. U.S.A. 93:3170-13175.
7. Conti, S., Magliani, W., Gerloni, M., Salati, A., Dieci, E., Arseni, S., Fisicaro, P., and Polonelli, L. (1998). A transphyletic anti-infectious control strategy based on the killer phenomenon. FEMS Immunol. Med. Microbiol. 22:151-161.
8. Doble, B. W., and Woodgett, J. R. (2003). GSK3β: Tricks of the trade for a multi-tasking kinase. J. Cell. Sci. 116:1175-1186.
9. Downward, J. (1998). Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell. Biol. 10:262-267.
10. Fitzpatrick, J. L., Mize, A. L., Wade, C. B., Harris, J. A., Shapiro, J. L., and Dorsa, D. M. (2002). Estrogen-mediated neuroprotection against β-amyloid toxicity requires expression of estrogen receptor α or β and activation of the MAPK pathway. J. Neurochem. 82: 674-682.
11. Forss-Petter, S., Denielson, P. E., Catsicas, S., Battenberg, E., Price, J., Nerenberg, M., and Sutcliffe, M. (1990). Transgenic mice expressing β-galactosidase in mature neuron under neuron-specific enolase promoter control. Cell. 5:187-197.
12. Gervais, F. G., Robertson, G. S., Vaillancourt, J. P., Zhu, Y., Huang, J., LeBlanc, A., Smith, D., Rigby, M., Shearman, M. S., Clarke, E. E., Zheng, H., van Der. Ploeg, L. H., Ruffolo, S. C., Thrnberry, N. A., Xanthoudakis, S., Zamboni, R. J., Roy, S., and Nicolson, D. W. (1999). Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-β precusor protein and amyloidogenic Aβ peptide formation. Cell 97: 395-406.
13. Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., and Selkoe, D. E. (1992). Amyloid-peptide is produced by cultured cells during normal metabolism. Nature 359:32-35.
14. Haass, C., and Stropper, B. (1999). The presenilin in Alzheimer's disease-proteolysis hold the key. Science 286:916-919.
15. Hwang, D. Y., Chae, K. R., Kang, T. S., Hwang, J. H., Lim, C. H., Kang, H. K., Goo, J. S., Lee, M. R., Lim, H. J., Min, S. H., Cho, J. Y., Hong, J. T., Song, C. W., Paik, S. G., Cho, J. S., and Kim, Y. K. (2002). Alterations in behavior, amyloid β-42, caspase-3, and Cox-2 in mutant PS2 transgenic mouse model of Alzheimer's disease. FASEB J. 16:805-813.
16. Hwang, D. Y., Cho, J. S., Lee, S. H., Chae, K. R., Lim, H. J., Min, S. H., Seo, S. J., Song, Y. S., Song, C. W., Paik, S. G., Sheen, Y. Y., and Kim, Y. K. (2004). Aberrant expressions of pathogenic phenotypes in Alzheimer's diseased transgenic mice carrying NSE-controlled APPsw. Exp. Neurol. 86:20-32.
17. Ida, N., Hartmann, T., Pantel, J., Schroeder, J., Zerfass, R., Foerstel, H., Sandbrink, R., Masters, C. L., and Beyreuther, K. (1996). Analysis of heterogeneous βA42 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay. J. Biol. Chem. 271:22908-22914.
18. Ishigura, K., Omori, A., Takematsu, M., Sato, K., Arioka, M., Uchida, T., and Imahori, K. (1992). Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments. Neurosci. Lett. 148:202-206.
19. Ishgura, K., Shiratsuchi, A., Sato, S., Omori, A., Arioka, M., Kobayashi, S., Ukida, T., and Imahori, K. (1993). Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Lett. 325:167-172.
20. Johnson, S. A., Rogers, J., and Finch, C. E. (1989). APP695 transcript prevalence is selectively reduced during Alzheimer's disease in cortex and hippocampus but not in cellebellum. Neurobiol. Aging 10:7557-7560.
21. Kammesheidt, A., Boice, F. M., Spanoyannis, A. F., Cumming, B. J., Ortegon, M., Cotman, C., Vaught, J. L., and Neve, R. L. (1992). Deposition of β/A4 immunoreactivity and neuronal pathway in transgenic mice expressing the carboxyl terminal fragment of the Alzheimer amyloid precursor in the brain. Proc. Natl. Acad. Sci. U.S.A. 89:10857-10861.
22. Kirschenbaum, F., Hsu, S. C., Cordell, B., and McCarthy, J. V. (2001) Glycogen synthase kinase-3β regulates presenilin 1 C-terminal fragment levels. J. Biol. Chem. 276:30701-30707.
23. Klafuki, H., Abramowski, D., Swoboda, R., Paganetti, P. A., and Staufenbiel, M. (1996). The carboxyl-termini of β amyloid peptides 1-40 and 1-42 are generated by distinct γ-secretase activities J. Biol. Chem. 271:28655-28659.
24. Liu, Z., Gastard, M., Verina, T., Bora, S., Mouton, P. R., and Koliatsos, V. E. (2001). Estrogens modulate experimentally induced apoptosis of granule cells in the adult hippocampus. J. Comp. Neurol. 44: 1-8.
25. Lovestone, S., Reynolds, C. H., Latimer, D., Davis, D. R., Anderton, B. H., Gallo, J. M., Hanger, D., Mulot, S., Marquardt, B., Stabel, S., Woodgett, J. R., and Miller, C. (1994). Alzheimer's disease like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr. Biol. 4:1077-1086.
26. Lucas, J. J., Hermandez, F., Gomez-Ramos, P., Moran, M. A., Hen, R., and Avila, J. (2001). Decreased nuclear β-catenin, tau hyperphosphorylation and neurodegeration in GSK-3β conditional transgenic mice. EMBO J. 20:27-39.
27. Manthey, D., Heck, S., and Behi, C. (2001). Estrogen induces a rapid secretion of amyloid β precusor protein via mitogen-activated protein kinas pathway. Eur. J. Biochem. 268:4285-4291.
28. McDonnell, D. P., Chang, C. Y., and Norris, J. D. (2001). Capitalizing the complexities of estrogen receptors pharmacology in the quest for the perfect SERM. Ann. N.Y. Acad. Sci. 949:16-35.
29. McKenna, N. J., and O'Malley, B. W. (2001). Nuclear receptor, coregulator, ligands, and selective receptor modulators: Making sense of the patch work guilt. Ann. NY. Acad. Sci. 949:3-5.
30. Means, A. R., Comstock, J. P., Rosenfield, G. C., and O'Malley, B. W. (1972). Ovalbumin messenger RNA of chick oviduct partial charaterization, estrogen dependence, and translation in vitro. Proc. Natl. Acad. Sci. U.S.A. 69:1146-1150.
31. Murphy, M. P., Hickman, L. J., Eckman, C. B., Uljon, S. N., Wang, R., and Golde, T. E. (1999). γ-Secreatse, evidence for multiple proteolytic activities and influence of membrane positioning of substrate on generation of amyloid β-peptide of varying length. J. Biol. Chem. 274:11914-11923.
32. Nalbantoglu, J., Tirado-Santiago, G., Lahsaini, A., Poirier, J., Goncalves, O., Verge, G., Momoli, F., Welner, S. A., Massicotte, G., Julien, J. P., and Shapiro, M. L. (1997). Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature 29:387(632), 500-505.
33. Oster-Granite, M. L., McPhie, D. L., Greenan, J., and Neve, R. L. (1996). Age-dependent neuronal and synaptic degeration in mice transgenic for the C Terminus of the amyloid precursor protein. J. Neurosci. 16:6732-6741.
34. Paech, K., Webb, P., Kuiper, G. G. J. M., Nilson, S., Gustafson, J. A., Kushner, P. J., and Scanlan, T. S. (1997). Differential ligand activation of estrogen receptors ERα and ERβ at AP1 site. Science 277:1508-1510.
35. Phiel, C. J., Wilson, C. A., Lee, V. M.-Y., and Klein, P. S. (2003). GSKα regulates production of AD amyloid-β peptides. Nature 4223:435-429
36. Sato, M., Kawarabayashi, T., Shoji, M., Kobayashi, T., Tada, N., Matsubara, E., and Hiraim, S. M. (1997). Neurogeneration and gliosis in transgenic mice overexpressing a carboxyl-terminal fragment of Alzheimer amyloid-β protein precursor. Dement. Geriatr. Cognit. Disorders 8:296-307.
37. Schenk, D., Barbour, R., Dunn, W., Gorden, G., Grajeda, H., Guido, T., Hu, K., Hung, J., Jhnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Liao, Z., Lieberburg. I., Matter, R., Mutter, L., Soriano, F., Shopp, G., Vasquenz, N., Vandevert, C., Walker, S., Wogulis, M., Yednoclk, T., Games, D., and Seubert, P. (1999). Immunization with amyloid β attenuates Alzheimer's disease-like pathology in the PDAAP mouse. Nature 400:173-177.
38. Sun, X., Sato, S., Murayama, O., Murayama, M., Park, J. M., Yamaguchi, H., and Takashima, A. (2002). Lithium inhibits amyloid secretion in COS cells transfected with amyloid precursor protein C100. Neurosci. Lett. 321:61-64.
39. Takashima, A., Honda, T., Yasutake, K., Michael, G., Murayama, O., Murayama, M., Ishiguro, K., and Yamaguchi, H. (1998A). Activation of tau protein kinase I and glycogen synthase kinase-3β by amyloid β peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Neurosci. Res. 31:317-323.
40. Takeshima, A., Murayama, M., Murayama, O., Kohno, T., Honda, T., Yasutake, K., Nihonmatsu, N., Merken, M., Yamaguchi, H., Sugihara, S., and Wolozin, B. (1998B). Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. Proc. Natl. Acad. Sci. 95:9637-9641.
41. Tesco, G., and Tanzi, R. E. (2000). GSK3β forms a tetrameric complex with endogenous PS1-CTF/NTF and β-catenin. Ann. New. York. Acad. Sci. 920:227-232.
42. Vogt, B. A., Crino, P. B., and Vogt, L. J. (1992). Recrganization of cinglulate cortex I Alzheimer's disease: neuron loss, neuritic plaques, and muscarinic receptor binding. Cereb. Cortex 2:526-535.
43. Wei, W., Norton, D. D., Wang, X., and Kusiak, J. W (2002). Aβ 17-42 in Alzheimer's disease activates JNK and caspase-8 leading to neuronal apoptosis. Brain 125:2036-2043
44. West, M. J. (1994). Differences in the pattern of hippocampal neuron loss in normal ageing and Alzheimer's disease. Lancet 344:526-535.